Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quinine sulfate 25mg/5ml oral liquid
0504010Y0AABBBB
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 50mg/5ml oral liquid
0504010Y0AAA4A4
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 75mg/5ml oral liquid
0504010Y0AAA3A3
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinsair 240mg nebuliser solution ampoules
0501120X0BDAAAF
|
Quinsair | Levofloxacin | Infections | No data available |
|
Quinupristin 150mg / Dalfopristin 350mg inf vials
0501070V0AAAAAA
|
Quinupristin/dalfopristin | Quinupristin/dalfopristin | Infections | No data available |
|
Raltegravir 100mg chewable tablets
0503010AEAAABAB
|
Raltegravir | Raltegravir | Infections | No data available |
|
Raltegravir 100mg granules for oral suspension sachets
0503010AEAAADAD
|
Raltegravir | Raltegravir | Infections | No data available |
|
Raltegravir 25mg chewable tablets
0503010AEAAACAC
|
Raltegravir | Raltegravir | Infections | No data available |
|
Ranclav 125mg/31mg/5ml SF oral suspension
0501013K0BDADAD
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 250mg/62mg/5ml SF oral suspension
0501013K0BDACAG
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 375mg tablets
0501013K0BDAAAA
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 625mg tablets
0501013K0BDABAJ
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranovir 200mg tablets
0503021C0BEAAAB
|
Ranovir | Aciclovir | Infections | No data available |
|
Rebetol 200mg capsules
0503050B0BEAAAB
|
Rebetol | Ribavirin | Infections | No data available |
|
Rebetol 40mg/ml oral solution
0503050B0BEABAH
|
Rebetol | Ribavirin | Infections | No data available |
|
Rekambys 900mg/3ml prolonged-release inj vials
0503010AGBCAAAB
|
Rekambys | Rilpivirine | Infections | No data available |
|
Relenza 5mg inhalation powder blisters with Diskhaler
0503040A0BBAAAA
|
Relenza | Zanamivir | Infections | No data available |
|
Renapime 1g powder for solution for injection vials
0501020ADBBAAAA
|
Renapime | Cefepime | Infections | No data available |
|
Renapime 2g powder for solution for injection vials
0501020ADBBABAB
|
Renapime | Cefepime | Infections | No data available |
|
Renoxitin 1g powder for solution for injection vials
0501021E0BCAAAD
|
Renoxitin | Cefoxitin sodium | Infections | No data available |
|
Renoxitin 2g powder for solution for injection vials
0501021E0BCABAE
|
Renoxitin | Cefoxitin sodium | Infections | No data available |
|
Reprapog 250mg/100mg tablets
0504010U0BCABAA
|
Reprapog | Proguanil hydrochloride with atovaquone | Infections | No data available |
|
Reprapog 62.5mg/25mg tablets
0504010U0BCAAAB
|
Reprapog | Proguanil hydrochloride with atovaquone | Infections | No data available |
|
Respillin 250mg capsules
0501013B0BNACAA
|
Respillin | Amoxicillin | Infections | No data available |
|
Respillin 500mg capsules
0501013B0BNADAB
|
Respillin | Amoxicillin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.